We are HomologyOur mission is focused on curing disease and transforming patients’ lives We are Homology We Are Homology Leadership Board of Directors Scientific Advisory Board Technology Platform AAVHSC Platform Gene Therapy Gene Editing GTx-mAb Publications and Presentations Pipeline Patients & Families Community Involvement Patient Stories Ava’s Story Tia’s Story Expanded Access Policy Clinical Trials Overview Gene Editing Clinical Trial for PKU Gene Therapy Clinical Trial for MPS II Culture & Careers Investors Overview Stock Information Stock Quote & Chart Historical Price Lookup Stock Calculator News & Events News Releases Investor Calendar Presentations Financial Information SEC Filings Annual Reports Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Investor Resources Email Alerts Contact IR Leadership“I joined Homology because I recognized the potential of the AAVHSC technology to provide unique genetic medicine approaches to address significant unmet medical need in the rare disease community, and I am proud to work with a team of dedicated colleagues working together towards delivering this goal.”Albert Seymour, Ph.D.President & Chief Executive Officer“It’s a pleasure working with my Homology colleagues who apply their own functional lens and the broader company perspective to work towards getting treatments to patients faster. I believe this focus is what has propelled our programs so quickly through development and into the clinic.”Brad Smith, M.B.A.Chief Financial & Business Officer“I came to Homology to be part of a team that steps up and does what it takes to get the job done. At all levels of the company there is commitment to do our best every day.”Deborah Kinch, Ph.D.Chief Development Officer“Homology has a unique combination of the “3 Ps” of a successful biotech company – a tireless effort to succeed on behalf of the patients our genetic medicines are designed to treat, a group of people across every function in the company, who are driven each day with a “we” attitude, and a platform that sets us apart from other companies working in the field.”Michael Blum, M.B.A.Chief Commercial Officer“Working at Homology to develop transformative life-changing therapies for patients with rare diseases with significant unmet need is a privilege. We know that every second counts for these patients, so we aim to work quickly and efficiently – but always with integrity and a focus on compliance, quality and safety.”Paul Alloway, Ph.D., J.D.Chief Legal Officer“I started my career in medicine because I have always wanted to help patients. I was drawn to Homology for the opportunity to develop and deliver potentially life-changing, one-time treatments to patients whose medical needs are not being met with current therapies.”Julie Jordan, M.D.Chief Medical Officer“Everyone we work with is someone we like to be with, in or outside of work, who motivate us, make us laugh, and genuinely care about one another. Together, we transform hope into help for rare diseases.”Melissa GelorminiSenior Vice President, Human ResourcesCara MayfieldVice President, Patient Advocacy and Corporate Communications